Medicare is wasting hundreds of millions of dollars a year by failing to rein in doctors who routinely give patients pricey name-brand drugs when cheaper generic alternatives are available.
A new analysis by ProPublica finds that many doctors in the U.S. prescribe brand-name drugs to Medicare patients when generics can be dramatically cheaper — and it's costing taxpayers hundreds of millions a year.
Medicare enrollment is already confusing enough. The new health care exchanges will only make it more so. And that could end up being costly for taxpayers.